ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 14 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,592 | -40.6% | 137,464 | 0.0% | 0.00% | – |
| Q1 2023 | $48,112 | +165803.4% | 137,464 | 0.0% | 0.00% | – |
| Q4 2022 | $29 | -99.9% | 137,464 | 0.0% | 0.00% | – |
| Q3 2022 | $48,000 | -73.6% | 137,464 | +1.2% | 0.00% | – |
| Q2 2022 | $182,000 | -32.8% | 135,889 | +0.6% | 0.00% | – |
| Q1 2022 | $271,000 | -22.3% | 135,102 | +4.5% | 0.00% | – |
| Q4 2021 | $349,000 | -15.3% | 129,327 | +34.6% | 0.00% | – |
| Q3 2021 | $412,000 | +83.1% | 96,077 | +8.9% | 0.00% | – |
| Q2 2021 | $225,000 | +19.7% | 88,246 | +13.2% | 0.00% | – |
| Q1 2021 | $188,000 | +42.4% | 77,985 | 0.0% | 0.00% | – |
| Q4 2020 | $132,000 | -23.7% | 77,985 | 0.0% | 0.00% | – |
| Q3 2020 | $173,000 | +60.2% | 77,985 | 0.0% | 0.00% | – |
| Q2 2020 | $108,000 | +6.9% | 77,985 | 0.0% | 0.00% | – |
| Q1 2020 | $101,000 | -73.0% | 77,985 | -50.0% | 0.00% | – |
| Q4 2019 | $374,000 | +222.4% | 155,970 | +100.0% | 0.00% | – |
| Q3 2019 | $116,000 | -11.5% | 77,985 | 0.0% | 0.00% | – |
| Q2 2019 | $131,000 | -50.9% | 77,985 | 0.0% | 0.00% | – |
| Q1 2019 | $267,000 | +93.5% | 77,985 | +187.1% | 0.00% | – |
| Q4 2018 | $138,000 | – | 27,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|